New T1DM Treatment From DiaVacs Inc Gets Orphan Drug Status

DV-0100 is proprietary, novel and safe. The therapy halts the body’s autoimmune reaction against the pancreatic islet cells which are responsible for producing insulin, allowing them to produce insulin normally and reversing the trajectory of the disease.

Read more

Posted in Type I Drugs